BIPH:OTO-Biophan Techs Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 16.66

Change

0.00 (0.00)%

Market Cap

USD 0.19M

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Biophan Technologies Inc develops and markets cutting-edge technologies for the medical device industry. It develops biomedical devices that improve the delivery of healthcare.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
BIPH VTI
  • VTI
Relative Returns (From:    To: 2025-04-05 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 57.94B
ALC Alcon AG

N/A

USD 46.01B
RMD ResMed Inc

N/A

USD 31.43B
BAX Baxter International Inc

N/A

USD 14.28B
AVTR Avantor Inc

N/A

USD 11.92B
SOLV Solventum Corp.

N/A

USD 11.45B
ATR AptarGroup Inc

N/A

USD 9.51B
TFX Teleflex Incorporated

N/A

USD 6.39B
STVN Stevanato Group SpA

N/A

USD 5.88B
BLCO Bausch + Lomb Corp

N/A

USD 4.29B

ETFs Containing BIPH

ARMR:AU Betashares Global Defence.. 8.83 % 0.00 %

N/A

N/A
XEYX:XETRA BNP Paribas Easy CAC 40®.. 5.84 % 0.00 %

N/A

USD 0.32B
WDEF:LSE WisdomTree Europe Defence.. 5.43 % 0.00 %

N/A

USD 0.02B
WDEP:LSE WisdomTree Europe Defence.. 5.43 % 0.00 %

N/A

N/A
DFND:SW iShares Global Aerospace .. 5.39 % 0.00 %

N/A

N/A
ASWC:XETRA HANetf ICAV - Future of D.. 5.22 % 0.00 %

N/A

USD 1.93B
C40:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
C4DE:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
PJIO PGIM ETF Trust 5.10 % 0.00 %

N/A

USD 0.01B
DEMZ Democratic Large Cap Core.. 4.78 % 0.00 %

N/A

USD 0.04B
STQX:SW SPDR® MSCI Europe Indust.. 4.69 % 0.00 %

N/A

USD 0.79B
JIG JPMorgan International Gr.. 3.48 % 0.00 %

N/A

USD 0.10B
CGGO Capital Group Global Grow.. 3.05 % 0.00 %

N/A

USD 5.20B
CAPI:CA Capital Group Internation.. 2.79 % 0.00 %

N/A

CAD 0.03B
CGGE Capital Group Global Equi.. 2.28 % 0.00 %

N/A

USD 0.24B
SPVM Invesco S&P 500 Value wit.. 1.85 % 0.39 %

N/A

USD 0.09B
AVSD American Century ETF Trus.. 0.69 % 0.00 %

N/A

USD 0.16B
AVDE Avantis® International E.. 0.56 % 0.00 %

N/A

USD 5.91B
EWQ iShares MSCI France ETF 0.00 % 0.47 %

N/A

N/A
FITE SPDR S&P Kensho Future Se.. 0.00 % 0.20 %

N/A

USD 0.09B
VAMO Cambria Value and Momentu.. 0.00 % 0.64 %

N/A

N/A
XRLV Invesco S&P 500® ex-Rate.. 0.00 % 0.25 %

N/A

N/A
ISFR:LSE iShares MSCI France UCITS 0.00 % 0.00 %

N/A

USD 0.16B
NDUS:LSE SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

N/A
LOWV:LSE SPDR® S&P 500 Low Volati.. 0.00 % 0.00 %

N/A

N/A
C40:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.78B
CAC:PA Amundi CAC 40 UCITS ETF D.. 0.00 % 0.00 %

N/A

USD 3.53B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

N/A

USD 0.67B
E40:PA BNP Paribas Easy CAC 40®.. 0.00 % 0.00 %

N/A

USD 0.23B
GWT:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.08B
STQ:PA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

USD 0.53B
EXH4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
GC40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
IQQG:F iShares Public Limited Co.. 0.00 % 0.00 %

N/A

N/A
IS3U:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
LGWT:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
SPY1:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

N/A
SPYQ:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
EL4C:XETRA Deka STOXX Europe Strong .. 0.00 % 0.00 %

N/A

USD 0.29B
DX2G:XETRA Xtrackers - CAC 40 UCITS .. 0.00 % 0.00 %

N/A

USD 0.12B
EXH4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.16B
GC40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
IQQG:XETRA iShares EURO Total Market.. 0.00 % 0.00 %

N/A

N/A
IS3U:XETRA iShares MSCI France UCITS 0.00 % 0.00 %

N/A

N/A
LGWT:XETRA Amundi MSCI Europe Growth.. 0.00 % 0.00 %

N/A

N/A
SPY1:XETRA SPDR® S&P 500 Low Volati.. 0.00 % 0.00 %

N/A

N/A
SPYQ:XETRA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

N/A
UBUR:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

N/A
UBUV:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

N/A
C4D:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.04B
ESIN:LSE iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

USD 0.54B
ESIN:F iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

N/A
ESIN:XETRA iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return 1.88% 100% F 80% B-
Total Return 1.88% 100% F 83% B
Trailing 12 Months  
Capital Gain -11.81% 72% C 30% F
Dividend Return 6.63% 100% F 84% B
Total Return -5.18% 72% C 38% F
Trailing 5 Years  
Capital Gain 8,230.00% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8,230.00% 100% F 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 66,041.74% 100% F 100% F
Dividend Return 66,044.95% 100% F 100% F
Total Return 3.21% 100% F 66% D+
Risk Return Profile  
Volatility (Standard Deviation) N/A 6% D- N/A F
Risk Adjusted Return 28.34% 89% A- 44% F
Market Capitalization 0.19M 7% C- N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative earnings

The company had negative total earnings in the most recent four quarters.